Same Contrast Dose, Different Risk of Kidney Injury, Depending on Procedure

The risk of contrast induced kidney injury is significantly lower in patients receiving transcatheter aortic valve replacement (TAVR) compared against patients getting a coronary angiography or angioplasty. 

Una nueva molécula para evitar la nefropatía por contraste

This is true even for valvular heart disease patients with higher risk profiles. 

Differences in contrast-induced acute kidney injury between TAVR or coronary patients had not been previously investigated.

This study published in J Am Heart Assoc retrospectively looked at patients undergoing elective TAVR and coronary procedures focusing especially in pre, and post-procedure kidney function. 

Contrast induced acute kidney injury (CI-AKI) was defined as relative increase in serum creatinine concentration of at least 0.3 mg/dL within 72 hours of contrast-medium administration compared with baseline. The study compared the incidence of CI-AKI after TAVR and coronary procedures.


Read also: Do We Need to See a Cardiologist before a Carotid Endarterectomy?


After excluding emergency procedures and patients in dialysis, 489 of the remaining patients received TAVR and 488 received coronary procedures. 

Patients undergoing TAVR resulted older, with more incidence of anemia and kidney deterioration (p<0.001 for all comparisons). TAVR patients consistently presented lower glomerular filtration and higher creatinine. 

Despite all the above mentioned, TAVR patients consistently presented lower CI-AKI vs. coronary patients (6.7% versus 14.5%, p<0.001).


Read also: Evidence or Theory? Antiaggregation Scheme after Peripheral Vascular Intervention.


After multivariable analysis, TAVR resulted an independent protection factor against post procedural CI-AKI. These outcomes were confirmed after propensity score matching. 

Conclusion

CI-AKI occurred less frequently in patients undergoing TAVR vs. coronary patients. The impact of contrast medium in TAVR patients might be better tolerated due to the hemodynamic changes that take place after valve implantation. 

JAHA-120-017194free

Original Title: Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions.

Reference: Gabriele Venturi et al. J Am Heart Assoc. 2020;9:e017194. DOI: 10.1161/JAHA.120.017194.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF), and a significant deterioration in quality of...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...